G-CSF is a well-known myeloid growth factor, and previous studies have assessed the use of G-CSF as a prophylactic measure during chemotherapy-induced neutropenia, for retreatment after prior cycles of neutropenic fever, and to reduce the duration of chemotherapy-related neutropenia in afebrile patients [22]. This evidence concerns the gene CSF3 and Decreased total neutrophil count.